UC BON.CAP.CERT. 09/24 AMD/ DE000HD3TH27 /
2024-05-02 12:46:03 PM | Chg.-21.310 | Bid1:05:47 PM | Ask1:05:47 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
168.870EUR | -11.21% | 169.270 Bid Size: 200 |
169.300 Ask Size: 200 |
Advanced Micro Devic... | - USD | 2024-09-27 | Call |
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
GlobeNewswire
05-01
Alkeus Pharmaceuticals Announces Presentation of Positive Gildeuretinol Data in Early-Stage Stargard...
GlobeNewswire
05-01
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geog...
GlobeNewswire
05-01
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
GlobeNewswire
05-01
Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology ...
GlobeNewswire
04-30
Lighthouse Guild Receives Grant from American Macular Degeneration Foundation (AMDF)
GlobeNewswire
04-25
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientif...
GlobeNewswire
04-18
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy